IFNG and cancer: Trm cells can release effector molecules and cytokines, such as interleukin-2, interferon-gamma (IFN-γ), tumour necrosis factor-α, and granzyme B. Sustained high expression of these factors may enable Trm cells to rapidly and strongly respond against cancer cells [24–31].